Methods. Late in 1997 a group of experts in the sciBackground. Tobacco use remains the leading cause ence of tobacco control was convened by the Center of preventable death in the United States. Although for the Advancement of Health to develop recommencomprehensive tobacco control has a number of essen-dations regarding the use of federal funds for treating tial components, support for cessation services can tobacco dependence. These recommendations were yield the largest short-term public health benefit. prepared based on the priority of the actions and the While effective treatments for tobacco dependence do estimated cost and effort required to implement them. exist, they are not currently available to many of the Following the Master Settlement Agreement in 1998, tobacco users who want and need them. Finding cost-the recommendations were adapted to address the effective, science-based strategies for reducing to-needs of state policy makers. bacco dependence in the United States should be a
METHODS
not being met: nearly 440,000 Americans will die of tobacco-related diseases this year [4] .
Late in 1997, a group of experts in tobacco control According to the U.S. Centers for Disease Control was convened by the Center for the Advancement of and Prevention, smoking cessation services can provide Health through a grant from SmithKline Beecham Conthe "quicker and probably larger short-term public sumer Healthcare. Members of this group represented health benefit than any other component of a compre-leading researchers and administrators with expertise hensive tobacco control program" [5] . Most adult smok-in addiction, tobacco-related diseases, health behavior ers in the United States want to stop smoking [6] , and and outcomes, health care economics, and health care proven, effective behavioral and pharmacological treat-policy. Many members had served on advisory panels ments do exist for tobacco dependence. These methods and committees to public and private organizations conwere recommended in the clinical practice guideline cerned with tobacco control. first released by the Agency for Health Care Policy and
The group engaged in a process of systematically reResearch (now the Agency for Healthcare Research and viewing the available information on the individual and Quality) in 1996 [7] , and were reaffirmed in the updated public health costs and outcomes of tobacco use and cessation. Evidence was collected on the range of serclinical practice guideline released by the Public Health vices available to treat tobacco dependence and assist Service in 2000 [8] . Evidence-based tobacco dependence in tobacco use cessation. Current data were also coltreatments are more cost-effective than a number of lected on tobacco use and addiction, the public health interventions that are now routinely paid for by insurcosts of continued usage, the estimated cost of providing ance, including mammograms and treatment for hypercessation services, and the availability of such services tension and hypercholesterolemia [9] . Indeed, treatto tobacco users. The group compiled these data and ment of tobacco dependence has been called the most examined them to assess gaps between tobacco users' cost-effective of all clinical preventive services [10] .
desires for cessation services and access to them and Despite this compelling evidence for the use of to-the most effective ways to address those gaps. bacco use cessation services, proven treatments are not widely available or used at this time. Although some
RESULTS AND RECOMMENDATIONS
progress has been made through expanded access to the nicotine patch and gum as nonprescription medicaState and federal legislation and/or executive action are needed to appropriate and allocate funds from a tions, as well as through the availability of new prevariety of sources (particularly tobacco settlement scription medications [11] [12] [13] , these products are not funds and tobacco tax revenues) to build and maintain inexpensive, and the immediate cost of cessation serthe capacity of health care systems to deliver, as a part vices to tobacco users remains high: Medicaid programs of routine care, effective tobacco-use treatment interin just 23 states and the District of Columbia cover any ventions to all who use tobacco products. Funds allotype of tobacco treatment services, and fewer still cover cated for tobacco-use cessation should be divided among pharmacotherapy [14, 15] . Furthermore, when treat-the following: basic treatment services, delivered ment for tobacco dependence is offered as a reimburs-within traditional health care settings; intensive treatable benefit from health care providers, a wide range ment services, delivered by health professionals trained of barriers may be in place which limit utilization of specifically in addiction treatment; quality assurance the benefit [16] .
for the services that are delivered; and research and Our state and national tobacco control policies must policy to develop more effective cessation services and address the need to make effective treatments available increase the range of incentives for abstinence from to the widest possible group of tobacco users. Treatment tobacco use. of tobacco dependence not only reduces morbidity and A. Basic Tobacco Dependence Treatment mortality, but also is cost effective. Given the price inInterventions creases tobacco companies have already put in place to cover their settlement costs, and the tobacco taxes that It is recommended that approximately 60% of funds many states have implemented, tobacco users deserve designated for tobacco use cessation be allocated to supto see some of the benefits of those revenues.
port basic treatment interventions that: This paper lays out clear, concise guidelines for state
• promote evidence-based 4 interventions as the stanand national policy makers, as well as health insurance dard of care for all clinicians; decision makers, regarding the effective use of funds to make high-quality cessation services, from basic to
• implement tobacco-user identification and monitor-or taxes are not likely to be available in perpetuity, so systemic changes are needed to ensure that service ing systems in every office and clinic and ensure that clinicians and patients have needed treatment re-delivery continues when the funds are depleted. Finally, insurers and health plans will be more likely to provide sources (e.g., staff trained to integrate tobacco use interventions into clinical services, reminder systems, and incentives to providers if they can be assured that good quality, effective interventions will delivered by efficacious, evidence-based patient aids and pharmacotherapies); trained clinicians. Funding should support the systems, competencies, • provide for treatment that can be accessed outside of the standard health care system, including telephone and resources needed to incorporate this standard of care into basic medical care. For instance, funds allohelplines and FDA-approved nonprescription medications.
cated to publicly and privately funded health care systems, clinics, provider organizations, and health plans Funding should be provided to establish and main-should ensure that: tain this basic level of treatment for all tobacco users in all health care settings, including nontraditional set-
• clinicians understand recommendations for, and tings such as school and workplace-based clinics and are trained to deliver, basic treatment services; community health centers and public systems such as
• clinicians and patients have access to a range of the Indian Health Service, military and Veterans' Af-treatment resources, from the Public Health Service fairs, Medicare, and Medicaid. The basic recommenda-guideline for smoking cessation, to resources provided tion, then, is that all health care clinicians (including by state and local health departments and organizaphysicians, nurses, dentists, hygienists, pharmacists, tions; respiratory therapists, health counselors, etc.) take the
• every office and clinic maintains tobacco-user idenfollowing steps with all patients: tification and monitoring systems to evaluate the deAsk-systematically identify tobacco use at every gree to which health care systems are meeting the basic visit; standard of care. Advise-strongly urge all tobacco users to quit; Assist-with brief (3-5 minutes) behavioral coun-B. Intensive Tobacco Dependence Treatment seling, the provision of treatment materials, and the Interventions recommendation/prescription of appropriate pharmacotherapy;
It is recommended that an additional 20-25 percent Arrange-follow-up support/referral to more inten-of treatment funds be used to develop the capacity to sive treatments if needed; deliver intensive treatment services to certain smokers Anticipate-assess and intervene to reduce the risk and to ensure access to treatment services for unfor tobacco use in children.
derserved populations. This would include: Rationale. Seventy percent of smokers see a clini-
• referral protocols for smokers needing more intencian each year [17] . If clinicians provided brief interven-sive treatment; tions to all smokers, the national annual quit rate could
• training for providers to deliver more intensive be more than doubled [18] . The addition of brief behav-treatments; ioral counseling and pharmacotherapy could more than
• training and/or certification to encourage and entriple the annual quit rate [19, 20] . Because basic inter-able the provision of targeted interventions to individuventions can have such a powerful effect at the popula-als with varying backgrounds and treatment needs; tion level, they are already promoted as the standard
• reimbursement for delivery of intensive treatment of care by health organizations including the National to low-income, uninsured, and publicly insured populaCommittee for Quality Assurance, the American Medi-tions. cal Association, the American Academy of Family Physicians, the National Cancer Institute, and the AmeriBuilding the capacity to provide intensive treatment can Cancer Society. In addition, basic services are both will require training practitioners to address ways in inexpensive and cost-effective: the Centers for Disease which to meet individual patient needs. Model proControl and Prevention estimates the cost of identifica-grams should be funded as well and should include tion and brief counseling to be $3 per smoker [21] .
programs tailored to serve specific cultural groups and Investing in developing the capacity for delivering patients with various physical and psychological health a basic level of treatment intervention, in addition to risks and conditions. paying individual clinicians for each encounter, is important for three reasons. First, the current health care
Rationale. While basic, low-cost interventions in medical and consumer settings are likely to reach the system lacks, at many levels, the capacity to treat smokers effectively. Second, funds from tobacco settlements majority of tobacco users, yielding by far the largest number of quitters, many tobacco users will require the highest quality and represent state-of-the-art modalities. The current best evidence regarding efficacious more intensive treatment services. Those in need of intensive treatment are often tobacco users with in-treatment methods is summarized in the 2000 Public Health Service clinical practice guideline. However, it creased health risks, (e.g., pregnancy, alcohol and other dependency problems, psychiatric comorbidities, life-is not clear that these interventions are being widely implemented. At the same time, treatments with little or limb-threatening tobacco-related diseases), making intensive intervention particularly cost-effective [22] . or no evidence to support their efficacy (e.g., lobeline sulfate and its varieties) are being marketed [23] . MechIn these cases, treatment should be readily accessible through providers with demonstrated proficiency in anisms must be developed to ensure that funds are not diverted to unproven or ineffective treatments. Also, a treating tobacco dependence.
Providing intensive treatment requires knowledge of mechanism should be established to update and promulgate new treatment guidelines as more effective the patient's tobacco dependence and previous quit attempts, the patient's physical and psychological health treatments become available.
Quality assurance also entails ensuring access to prostatus, pharmacologic treatment options, counseling and other behavioral support techniques, and criteria viders who are knowledgeable and proficient in delivering state-of-the-art treatments. Health professions for determining the type and scope of treatment required. In general, intensive treatments involve a com-educational curricula generally do not include formal programs or clinical training in the treatment of tobacco bination of components, including multiple treatment encounters, application of both behavioral and pharma-dependence, nor are there standardized criteria for continuing medical education or training. Treatment of cological interventions, individual or group counseling and follow-up, and treatment of coexisting physical or tobacco dependence should be a standard component of the training of physicians and nurses, dentists and psychological conditions.
Funds also should be made available to reduce finan-hygienists, pharmacists, health counselors, and allied health professionals. cial barriers to accessing treatment by reimbursing the delivery of intensive treatments through Medicare and There is currently no way for consumers, third-party payers, and health systems to determine whether indiMedicaid, the Indian Health Service, and HRSAsupported clinics and health departments, as well as for vidual practitioners possess the requisite knowledge and skills to provide high-quality treatment services. people who lack health insurance coverage. In addition, studies should be funded to determine whether health Given the need to provide quality care, it is essential that proficiency standards be established at the naplans and third-party payers would be encouraged to establish or expand and maintain coverage for treat-tional level. The Secretary of Health and Human Services should be directed to develop such standards and ment services if incentive programs-such as state or federal regulations, inclusion in health plan accredita-to provide states with models for adaptation and adoption of such standards; this should include standards tion or reporting indices, or appropriation of tobacco settlement monies-were established.
for training and certification or licensing of health professionals and others engaged in the delivery of treatment services.
C. Enhancing Quality of Treatment Services
Activities are also needed to promote the use of qualIt is recommended that another 10-15% of treatment ity control measures for both voluntary and mandatory funds be allocated to assure the quality of both basic treatment programs. These should be integrated with and intensive treatment services by establishing proce-existing quality control measures (e.g., HEDIS indicadures for: tors) for other clinical interventions. Monitoring will allow feedback to providers, health systems administra-• ensuring that treatment is guided by the best avail-tors, purchasers, regulatory agencies, and accrediting able effectiveness and cost-effectiveness data;
organizations to assess the quality of treatment ser-• developing curricula for training and/or certifying vices being provided. Therefore, funding for programs health professionals in the skills and knowledge needed should be contingent upon the incorporation of reasonto deliver basic and intensive treatment services; able monitoring methods into service delivery.
• monitoring program impact.
D. Related Needs The proportions of allocations recommended here
Finally, it is recommended that 5-10% of funds alloapply to the current need for capacity-building; these cated to the treatment of tobacco dependence be used proportions should be altered over time to respond to to support other research and policy efforts. Substantial changing circumstances.
portions of all funds allocated for biomedical and behavioral research should be dedicated to developing inRationale. Systems should be put into place to ensure that both basic and intensive treatments are of creasingly effective tobacco treatment interventions, particularly for underserved and high-risk populations. expand the research funding pool and not be diverted from or used to replace existing funds. In addition, broader tobacco prevention and control activities, such as media campaigns and policy changes, In order to increase tobacco users' interest in quitting should incorporate tobacco dependence treatment and to better support their current desires and efforts strategies.
to do so, clinical interventions need to be coordinated Rationale. Research into the processes of tobacco with broader tobacco-use prevention and control actividependence and its treatment has greatly advanced ties. Activities which would be likely to increase interest our ability to help smokers quit [24] , and research on in quitting among tobacco users include, as examples: nicotine and tobacco can significantly benefit public
• media messages, which should not only advocate health [25] . However, the level of funding currently against initiation of the use of tobacco products, but devoted to tobacco-use research is insufficient relative also promote available behavioral and pharmacological to the public health costs of continued tobacco use [26] .
treatments for tobacco dependence; local media mesMany national and international organizations consages should provide information on how to access supcerned with public health-including the National Canport services such as treatment clinics and hotlines; cer Institute, the World Health Organization, Health
• policy changes, which should include clean indoor Canada, and others-have set priorities for tobacco use air laws and an increase in the price of cigarettes; research, based on extensive literature reviews and con-
• worksite smoking bans, which could be accompasultative processes, which include improving options nied by incentives such as reduced health care premifor and delivery of treatment services. For example, ums for nonsmokers. research has been sparse on the treatment needs of specific populations of tobacco users, and existing treatFinally, smokers' access to proven interventions, parment methods may be ineffective or unacceptable for ticularly for those smokers who do not regularly use some tobacco users. Funds should therefore be lever-the health care system, could be improved by increasing aged from a variety of sources to support continued funding for public health interventions such as teleresearch in the following areas: phone hotlines, counseling services, and referral services to existing providers.
• assessing and treating tobacco-dependent youth [27], with attention to the different forms of tobacco CONCLUSION used, (e.g., smokeless tobacco, cigarettes, cigars, and bidis 5 ) [28] ; We can make a dramatic impact on the overall rate • enhancing treatment effectiveness among other of tobacco use and tobacco-related diseases in this counhigh-risk or poorly studied populations, including racial try by delivering low-cost, low-intensity interventions and ethnic minorities [29] , the elderly, and women to large numbers of smokers using existing health care [30, 31] (particularly during pregnancy [32] ); channels. Attention to tobacco use should be as routine • increasing the understanding of tobacco depenas attention to blood pressure during all medical dence and treatment among users of smokeless tobacco, encounters. cigars, and pipes [33] ; Many smokers will require more intensive treatment • evaluating new and innovative approaches includfrom trained providers-particularly those smokers ing more intensive behavioral therapies, new pharmawith more severe addictions, with psychiatric comorbidcotherapies, and combination therapies [34] ; ities, or facing illnesses or other factors complicating • expanding the acceptability, reach, and utilization their care. It is especially critical that effective intervenof, as well as adherence to, treatment programs [35] ; tions be available to smokers with conditions such as • increasing the understanding around the reasons cardiac disease, vascular disease, or diabetes, where why treatment programs and quit attempts may fail immediate reduction in smoking is necessary in the [36, 37] ; management of the condition.
• improving the integration of relevant treatment Unfortunately, our nation currently lacks the capacservices into general health care settings; ity to deliver effective basic and intensive treatments • providing incentives to practitioners to deliver efto all those who need them. State and federal policy fective treatments.
makers thus have an important obligation to allocate It is critical that new funds for treatment research funds to improve the delivery of tobacco dependence treatment services, and in allocating these funds, the 5 Bidis are small, brown cigarettes made in countries in southeast highest priority must be assigned to developing the Asia in which tobacco is rolled in tendu or temburni leaves instead systems, competencies, and resources needed to deliver of paper; they often come in appealing flavors, such as chocolate and and monitor integrated, evidence-based treatments to mango, and they are popular among youth. Typically, bidis deliver more carbon monoxide, tar, and nicotine than other cigarettes. tobacco users.
